JP2022542294A5 - - Google Patents

Info

Publication number
JP2022542294A5
JP2022542294A5 JP2022505585A JP2022505585A JP2022542294A5 JP 2022542294 A5 JP2022542294 A5 JP 2022542294A5 JP 2022505585 A JP2022505585 A JP 2022505585A JP 2022505585 A JP2022505585 A JP 2022505585A JP 2022542294 A5 JP2022542294 A5 JP 2022542294A5
Authority
JP
Japan
Prior art keywords
protein
functional fragment
seq
modified
mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022505585A
Other languages
English (en)
Japanese (ja)
Other versions
JP7887666B2 (ja
JP2022542294A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044559 external-priority patent/WO2021022187A1/en
Publication of JP2022542294A publication Critical patent/JP2022542294A/ja
Publication of JP2022542294A5 publication Critical patent/JP2022542294A5/ja
Priority to JP2025139669A priority Critical patent/JP2026000908A/ja
Application granted granted Critical
Publication of JP7887666B2 publication Critical patent/JP7887666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022505585A 2019-08-01 2020-07-31 抗体に結合して中和抗体を阻害するための組成物および方法 Active JP7887666B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025139669A JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881765P 2019-08-01 2019-08-01
US62/881,765 2019-08-01
PCT/US2020/044559 WO2021022187A1 (en) 2019-08-01 2020-07-31 Compositions and methods for binding antibodies and inhibiting neutralizing antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025139669A Division JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2022542294A JP2022542294A (ja) 2022-09-30
JP2022542294A5 true JP2022542294A5 (cg-RX-API-DMAC7.html) 2023-08-01
JP7887666B2 JP7887666B2 (ja) 2026-07-10

Family

ID=74230547

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022505585A Active JP7887666B2 (ja) 2019-08-01 2020-07-31 抗体に結合して中和抗体を阻害するための組成物および方法
JP2025139669A Pending JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025139669A Pending JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Country Status (9)

Country Link
US (1) US20220260563A1 (cg-RX-API-DMAC7.html)
EP (1) EP4007768A4 (cg-RX-API-DMAC7.html)
JP (2) JP7887666B2 (cg-RX-API-DMAC7.html)
CN (1) CN114514239A (cg-RX-API-DMAC7.html)
AU (1) AU2020319880B2 (cg-RX-API-DMAC7.html)
CA (1) CA3149679A1 (cg-RX-API-DMAC7.html)
IL (1) IL290219A (cg-RX-API-DMAC7.html)
MX (1) MX2022001425A (cg-RX-API-DMAC7.html)
WO (1) WO2021022187A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230152008A (ko) * 2021-02-03 2023-11-02 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 단백질 m 유사체 및 융합 단백질 및 이들의 항체 기능 억제 용도
WO2023125974A1 (zh) * 2021-12-31 2023-07-06 广州国家实验室 mRNA疫苗
CN115047188A (zh) * 2022-06-10 2022-09-13 上海鼎新基因科技有限公司 一种抗腺相关病毒中和抗体的检测方法
CN122127433B (zh) * 2026-04-29 2026-07-17 中国海洋大学 一种抗原表位多肽及其制备的牙鲆mAChR3特异性抗体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804183A (en) * 1997-01-31 1998-09-08 Enzon, Inc. Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
EP2782596A4 (en) * 2011-11-22 2015-07-29 Philadelphia Children Hospital VIRUS VECTORS FOR HIGHLY EFFICIENT TRANSGENIC ADMINISTRATION
AU2013204555A1 (en) * 2012-04-30 2013-11-14 Oncolytics Biotech Inc. Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
US9593150B2 (en) * 2012-07-16 2017-03-14 The Scripps Research Institute Immunoglobulin-binding human mycoplasma antigens and methods of use thereof
EP3099320A4 (en) * 2014-01-31 2018-04-18 The Scripps Research Institute Protein m related immunoglobulin-binding polypeptides
CN107002096A (zh) * 2014-10-06 2017-08-01 阿罗根有限公司 基于aav的基因疗法
CA3001941A1 (en) * 2015-10-30 2017-05-04 Nbe-Therapeutics Ag Anti-ror1 antibodies
DE102016123859B3 (de) * 2016-12-08 2018-03-01 Immatics Biotechnologies Gmbh Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie

Similar Documents

Publication Publication Date Title
US7968512B2 (en) Conjugates that contain the homeodomain of antennapedia
AU2001292619A1 (en) Novel compounds
WO2002022802A1 (en) Novel compounds
JP2004500100A (ja) 新規化合物
JP2004321100A (ja) IgGのFc領域を含むタンパク質の変異体
CN118221829A (zh) 一种il-10单体融合蛋白
CN110845596B (zh) 突变体xSUMO及其相关产品
CN102766202B (zh) Phf14 c端蛋白、其多克隆抗体及应用
CN106317225A (zh) 具有靶向性长效白细胞介素22融合蛋白及其制备方法和用途
JPH11507825A (ja) Dnアーゼ活性を有する蛋白質
JP2000506733A (ja) チロシンホスファターゼ関連タンパク質
JP2002514417A (ja) Rhoの推定上の標的であるロテキン
JPH11510382A (ja) トランスケトラーゼ関連蛋白質
EP1274842A2 (en) Lipid binding protein 4
CN1318448C (zh) 一种重组全长人脑红素、其生产方法及其应用
JP2008500006A (ja) ペプチド複合体
JP2003523748A (ja) 新規ホスホジエステラーゼ7b型
JP2024521368A (ja) 環状RNA Circ-ACE2翻訳によるポリペプチド及びその使用
US20050107592A1 (en) Lipid binding protein 1
CA3148273A1 (en) Compositions and methods utilizing a novel human foxo3 isoform
EP1274845A2 (en) Lipid binding protein 3
McAfee Genetic and DNA binding studies on a 7 kDa protein from Sulfolobus acidocaldarius.
JP2000500962A (ja) Fmr1関連蛋白質
WO2001030818A1 (fr) Nouveau polypeptide, proteine de liaison 33 a l'arn, et polynucleotide codant pour ce polypeptide
EP1274843A1 (en) New lipid binding protein 2